Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TENS of Auricular Vagal Nerve for Radiation Necrosis

NCT: NCT07680127 · NOT_YET_RECRUITING

NCT IDNCT07680127
StatusNOT_YET_RECRUITING
Start Date2026-07-31
Completion2029-08-31
SponsorVirginia Commonwealth University (OTHER)
First posted
Last updated

Brief Summary

This is a multi-center, randomized, blinded trial evaluating the effect of transcutaneous auricular vagal nerve stimulator (taVNS) on radiation necrosis-related cerebral edema. In this study, consenting and eligible patients will be assigned to one of two arms: treatment (Arm 1) or sham (Arm 2). Patients in both arms will have imaging performed and tissue and blood collected for assessment of changes in area of contrast enhancement and cerebral edema, inflammatory markers, and markers of blood-brain barrier permeability.

Frequently Asked Questions

What is TENS of Auricular Vagal Nerve for Radiation Necrosis?

TENS of Auricular Vagal Nerve for Radiation Necrosis is a clinical trial registered under NCT07680127. Current status: NOT_YET_RECRUITING.

What is the status of NCT07680127?

The current status of NCT07680127 (TENS of Auricular Vagal Nerve for Radiation Necrosis) is: NOT_YET_RECRUITING.

When did TENS of Auricular Vagal Nerve for Radiation Necrosis start?

TENS of Auricular Vagal Nerve for Radiation Necrosis started on 2026-07-31.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.